These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1668041)

  • 1. Coupling of receptors to G proteins, pharmacological implications.
    Bockaert J
    Therapie; 1991; 46(6):413-20. PubMed ID: 1668041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.
    Guan XM; Amend A; Strader CD
    Mol Pharmacol; 1995 Sep; 48(3):492-8. PubMed ID: 7565630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of G protein-mediated signal transduction in molecular pharmacodynamics].
    Schütz W; Freissmuth M; Nanoff C; Selzer E; Tuisl E
    Wien Klin Wochenschr; 1990 Oct; 102(20):602-9. PubMed ID: 2175069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The G protein-coupling profile of metabotropic glutamate receptors, as determined with exogenous G proteins, is independent of their ligand recognition domain.
    Parmentier ML; Joly C; Restituito S; Bockaert J; Grau Y; Pin JP
    Mol Pharmacol; 1998 Apr; 53(4):778-86. PubMed ID: 9547371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-protein-coupled receptors for neurotransmitter amino acids: C-terminal tails, crowded signalosomes.
    El Far O; Betz H
    Biochem J; 2002 Jul; 365(Pt 2):329-36. PubMed ID: 12006104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic approaches to the determination of structure-function relationships of G protein-coupled receptors.
    Strader CD; Sigal IS; Dixon RA
    Trends Pharmacol Sci; 1989 Dec; Suppl():26-30. PubMed ID: 2559516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [G-proteins coupled receptors].
    Thibonnier M
    Rev Prat; 1994 May; 44(9):1163-7. PubMed ID: 7939337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular tinkering of G protein-coupled receptors: an evolutionary success.
    Bockaert J; Pin JP
    EMBO J; 1999 Apr; 18(7):1723-9. PubMed ID: 10202136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The molecular mechanisms of the interaction of hormonal receptors coupled with G-proteins].
    Voeĭkov VL; Kiselev OG
    Fiziol Zh SSSR Im I M Sechenova; 1990 Sep; 76(9):1138-44. PubMed ID: 1963854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
    J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of interactions of receptors and effectors with GTP-binding proteins in native membranes.
    Milligan G; Mullaney I; McKenzie FR
    Biochem Soc Symp; 1990; 56():21-34. PubMed ID: 2175190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of a C-terminal Gbetagamma-binding domain of Ca(v)2.2 channels.
    Li B; Zhong H; Scheuer T; Catterall WA
    Mol Pharmacol; 2004 Sep; 66(3):761-9. PubMed ID: 15322269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.
    Cavasotto CN; Orry AJ; Abagyan RA
    Proteins; 2003 May; 51(3):423-33. PubMed ID: 12696053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.
    Lane JR; Powney B; Wise A; Rees S; Milligan G
    J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic acetylcholine receptors: typical G-coupled receptors.
    Hulme EC
    Symp Soc Exp Biol; 1990; 44():39-54. PubMed ID: 2130518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling and heterotrimeric G-proteins: strange bedfellows or a classic romance?
    Malbon CC; Wang H; Moon RT
    Biochem Biophys Res Commun; 2001 Sep; 287(3):589-93. PubMed ID: 11563835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biotechnology of beta-adrenergic receptors].
    Strosberg D
    Pathol Biol (Paris); 1992 Oct; 40(8):767-72. PubMed ID: 1336596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SH3 binding domains in the dopamine D4 receptor.
    Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
    Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.